Search

everythinglearnresearchcommunity

for

Search:↓

Isotretinoin is effective for severe acne but requires careful monitoring for side effects, especially in women who could become pregnant.

Tofacitinib treatment is used for teenagers with alopecia areata.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

Medical Hair Restoration added a non-surgical hair therapy program to help people with early hair loss.

5-alpha reductase inhibitors do not increase osteoporosis risk in women with certain hair loss conditions.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

Tenofovir is more effective than adefovir for resistant hepatitis B, Fibroscan is good for assessing liver damage, regulatory T cells may help hepatitis C persist, and other insights into liver health and disease were found.

Etanercept may not prevent alopecia areata from coming back.

The document concludes that early diagnosis of Balint's syndrome is crucial for effective treatment and that understanding drug interactions, like between ritonavir and statins, is important for patient care.

Tofacitinib may be an effective and safe treatment for hair loss in teenagers with alopecia areata.

Ruxolitinib can help regrow hair in severe alopecia areata.

The authors maintain that shorter androgen receptor alleles may lead to milder COVID-19 by positively affecting the immune response, not due to changes in testosterone levels or activity.

Various dermatologic treatments were effective for skin conditions like acne, rosacea, hair loss, and psoriasis from December 1986 to December 1987.

The trial on testosterone replacement therapy in older men faced concerns due to prostate cancer risk.

Combining oral isotretinoin and rifampicin effectively treats folliculitis decalvans.

Intramuscular triamcinolone acetonide is an effective treatment for severe alopecia areata, especially in males.

CD8+ T cells re-expressing CD45RA may predict treatment resistance in severe alopecia areata.

More frequent PRP sessions with shorter intervals improve hair loss treatment.

Enzalutamide, a prostate cancer drug, may help prevent COVID-19 by blocking the virus from entering lung cells.

PROTACs show promise in cancer treatment by effectively degrading specific harmful proteins.

Taking 5-Alpha Reductase Inhibitors before bladder removal surgery might make high-grade bladder tumors less aggressive.

Pantotherapy is more effective for treating androgenetic alopecia than darsonvalization.

Androgen deprivation therapy doesn't lower the risk of death from COVID-19 in prostate cancer patients.

The document concludes that drug repurposing, which is reusing known medicines for new illnesses, can provide faster, cheaper treatment options for various serious diseases, including cancer, COVID-19, and rare diseases.

4-(Ethoxycarbophenyl) retinamide is much less toxic than other retinoids.

Oral tofacitinib is a promising treatment for beard hair loss in alopecia areata.

RT1640 treatment reverses gray hair and promotes hair growth in mice.

Tailored treatments for alopecia areata show promising results, with pulse steroids effective for mild cases and Ritlecitinib, Dupilumab, or methotrexate and prednisone effective for severe cases.

Androgen receptor degrader drugs may be a promising future treatment for hair loss.

5α-reductase inhibitors may worsen sexual drive and spontaneous erections but don't worsen existing erectile or ejaculatory problems.